Skip to content

DR. PHILIPPE BREWAEYS

Active
Private limited companyfounded 200026 years activeLange Lozanastraat 115, 2018 Antwerpen, BelgiumKBO/BCE: BE 0472.695.054
Summary

DR. PHILIPPE BREWAEYS has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €578,039 and a net result of €127,932. Equity is growing by ~31.4% per year across the filed fiscal years. Its solvency ranks better than 69% of 20,374 sector peers (NACE 86, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Risk analysisWatch ReportCompare
DR. PHILIPPE BREWAEYSActiveChecked score 96/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€729,442total assets 2025
Staff
1 FTE
Equity
€578,039
Profit
€127,932
Turnover not published (abridged schema)
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts filed 18 days late0 of 5 deeds read
Why 96+ Liquidity: current ratio 7.27, cash €428,087+ Sector Human health activities (NACE 86)+ Equity €578,039 (79.2% of total assets)+ Size: total assets €729,442Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 72% of its sector peers (NACE 86, micro)
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 100+5
equity 79.2% of total assets
Liquidity 99+3
short-term debt 11.5% · cash 58.7%
Profitability 91-5
return on assets 17.5%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,979 companies)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025highest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit up to €55,000 at 30 days acceptable
Liquidity ample (current ratio 7.27 against 4.93 in 2024; short-term debt: 11.5% and cash: 58.7% of total assets), and 20.8% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 89% on liquidity, 46% on profitability and 71% on growth.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk○neutral
lowers risk · Liquidity: current ratio 7.27, cash €428,087
NBB · annual accounts
lowers risk · Sector Human health activities (NACE 86)
KBO
lowers risk · Equity €578,039 (79.2% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €729,442
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
neutral · A punctual record breaks
This company filed 9 consecutive financial years on time. The year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 18-11-2025, 18 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filings
Deviation from the deadline
2025
18 days late
2024
9 days early
2023
25 days early
2022
11 days early
2021
34 days early
2020
19 days early
2019
23 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 15 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today. Usually files around 20 October (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
31-03-2026 close08-10-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Equity above €500,000Eq €578,039 ▲28.4%
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Positive: Among the best 15% on equitysector median €124,492 · 20,377 companies €578,039 View
  • Positive: 7 profitable years in a rowprofit 2025: €127,932 7 years View
  • Positive: Equity rose in 2025from €450,107 to €578,039 ▲ 28.4% View

By topic

Financials

Fiscal year
2025
Total assets
€729,442
Profit
€127,932
Solvency
79.2%
Total assets▲ 14.2%
Net result
20192025
Go to Financials

Timeline

Events
15
Since
2016
Next accounts
by 31-10-2026
  1. 31-03-2024Highest result since 2019
  2. 06-10-2023Annual accounts filed
  3. 20-10-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
13-09-2000
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure